Characterization of the Interface of the Bone Marrow Stromal Cell Antigen 2-Vpu Protein Complex via Computational Chemistry

被引:14
作者
Zhou, Jinming [1 ]
Zhang, Zhixin [1 ]
Mi, Zeyun [1 ]
Wang, Xin [1 ]
Zhang, Quan [1 ]
Li, Xiaoyu [1 ]
Liang, Chen [2 ,3 ]
Cen, Shan [1 ]
机构
[1] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100730, Peoples R China
[2] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada
[3] McGill Univ, Jewish Gen Hosp, McGill AIDS Ctr, Montreal, PQ H3T 1E2, Canada
关键词
VPU TRANSMEMBRANE DOMAIN; HIV-1; VPU; BETA-TRCP; MEMBRANE; RESTRICTION; BST-2; SIMULATION; PEPTIDES; RELEASE; HELIX;
D O I
10.1021/bi2015986
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bone marrow stromal cell antigen 2 (BST-2) inhibits the release of enveloped viruses from the cell surface. Various viral counter measures have been discovered, which allow viruses to escape BST-2 restriction. Human immunodeficiency virus type 1 (HIV-1) encodes viral protein U (Vpu) that interacts with BST-2 through their transmembrane domains and causes the downregulation of cell surface BST-2. In this study, we used a computer modeling method to establish a molecular model to investigate the binding interface of the transmembrane domains of BST-2 and Vpu. The model predicts that the interface is composed of Vpu residues I6, A10, A14, A18, V25, and W22 and BST-2 residues L23, I26, V30, I34, V35, L41, I42, and T45. Introduction of mutations that have been previously reported to disrupt the Vpu BST-2 interaction led to a calculated higher binding free energy (MMGBSA), which supports our molecular model. A pharmacophore was also generated on the basis of this model. Our results provide a precise model that predicts the detailed interaction occurring between the transmembrane domains of Vpu and BST-2 and should facilitate the design of anti-HIV agents that are able to disrupt this interaction
引用
收藏
页码:1288 / 1296
页数:9
相关论文
共 43 条
  • [11] Performance of the general amber force field in modeling aqueous POPC membrane bilayers
    Jojart, Balazs
    Martinek, Tamas A.
    [J]. JOURNAL OF COMPUTATIONAL CHEMISTRY, 2007, 28 (12) : 2051 - 2058
  • [12] Identification of Amino Acids in the Human Tetherin Transmembrane Domain Responsible for HIV-1 Vpu Interaction and Susceptibility
    Kobayashi, Tomoko
    Ode, Hirotaka
    Yoshida, Takeshi
    Sato, Kei
    Gee, Peter
    Yamamoto, Seiji P.
    Ebina, Hirotaka
    Strebel, Klaus
    Sato, Hironori
    Koyanagi, Yoshio
    [J]. JOURNAL OF VIROLOGY, 2011, 85 (02) : 932 - 945
  • [13] Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models
    Kollman, PA
    Massova, I
    Reyes, C
    Kuhn, B
    Huo, SH
    Chong, L
    Lee, M
    Lee, T
    Duan, Y
    Wang, W
    Donini, O
    Cieplak, P
    Srinivasan, J
    Case, DA
    Cheatham, TE
    [J]. ACCOUNTS OF CHEMICAL RESEARCH, 2000, 33 (12) : 889 - 897
  • [14] Assembly of Viral Membrane Proteins
    Krueger, J.
    Fischer, W. B.
    [J]. JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2009, 5 (09) : 2503 - 2513
  • [15] The HIV-1 Vpu Viroporin Inhibitor BIT225 Does Not Affect Vpu-Mediated Tetherin Antagonism
    Kuhl, Bjoern D.
    Cheng, Vicky
    Donahue, Daniel A.
    Sloan, Richard D.
    Liang, Chen
    Wilkinson, John
    Wainberg, Mark A.
    [J]. PLOS ONE, 2011, 6 (11):
  • [16] Tetherin and Its Viral Antagonists
    Kuhl, Bjoern D.
    Cheng, Vicky
    Wainberg, Mark A.
    Liang, Chen
    [J]. JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2011, 6 (02) : 188 - 201
  • [17] Molecular dynamics investigation of membrane-bound bundles of the channel-forming transmembrane domain of viral protein U from the human immunodeficiency virus HIV-1
    Lopez, CF
    Montal, M
    Blasie, JK
    Klein, ML
    Moore, PB
    [J]. BIOPHYSICAL JOURNAL, 2002, 83 (03) : 1259 - 1267
  • [18] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VPU PROTEIN IS AN OLIGOMERIC TYPE-I INTEGRAL MEMBRANE-PROTEIN
    MALDARELLI, F
    CHEN, MY
    WILLEY, RL
    STREBEL, K
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (08) : 5056 - 5061
  • [19] Origins of Resistance to the HIVgp41 Viral Entry Inhibitor T20
    McGillick, Brian E.
    Balius, Trent E.
    Mukherjee, Sudipto
    Rizzo, Robert C.
    [J]. BIOCHEMISTRY, 2010, 49 (17) : 3575 - 3592
  • [20] Species-Specific Activity of HIV-1 Vpu and Positive Selection of Tetherin Transmembrane Domain Variants
    McNatt, Matthew W.
    Zang, Trinity
    Hatziioannou, Theodora
    Bartlett, Mackenzie
    Ben Fofana, Ismael
    Johnson, Welkin E.
    Neil, Stuart J. D.
    Bieniasz, Paul D.
    [J]. PLOS PATHOGENS, 2009, 5 (02)